| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |